The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; none of the 5 sources its claims cite is checked for support yet.
Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study
Open accessAbstract
BACKGROUND: The SARS-CoV-2 delta (B.1.617.2) variant was first detected in England in March, 2021. It has since rapidly become the predominant lineage, owing to high transmissibility. It is suspected that the delta variant is associated with more severe disease than the previously dominant alpha (B.1.1.7) variant. We aimed to characterise the severity of the delta variant compared with the alpha variant by determining the relative risk of hospital attendance outcomes. METHODS: This cohort study was done among all patients with COVID-19 in England between March 29 and May 23, 2021, who were identified as being infected with either the alpha or delta SARS-CoV-2 variant through whole-genome sequencing. Individual-level data on these patients were linked to routine health-care datasets on vaccination, emergency care attendance, hospital admission, and mortality (data from Public Health England's Second Generation Surveillance System and COVID-19-associated deaths dataset; the National Immunisation Management System; and NHS Digital Secondary Uses Services and Emergency Care Data Set). The risk for hospital admission and emergency care attendance were compared between patients with sequencing-confirmed delta and alpha variants for the whole cohort and by vaccination status subgroups. Stratified Cox regression was used to adjust for age, sex, ethnicity, deprivation, recent international travel, area of residence, calendar week, and vaccination status. FINDINGS: Individual-level data on 43 338 COVID-19-positive patients (8682 with the delta variant, 34 656 with the alpha variant; median age 31 years [IQR 17-43]) were included in our analysis. 196 (2·3%) patients with the delta variant versus 764 (2·2%) patients with the alpha variant were admitted to hospital within 14 days after the specimen was taken (adjusted hazard ratio [HR] 2·26 [95% CI 1·32-3·89]). 498 (5·7%) patients with the delta variant versus 1448 (4·2%) patients with the alpha variant were admitted to hospital or attended emergency care within 14 days (adjusted HR 1·45 [1·08-1·95]). Most patients were unvaccinated (32 078 [74·0%] across both groups). The HRs for vaccinated patients with the delta variant versus the alpha variant (adjusted HR for hospital admission 1·94 [95% CI 0·47-8·05] and for hospital admission or emergency care attendance 1·58 [0·69-3·61]) were similar to the HRs for unvaccinated patients (2·32 [1·29-4·16] and 1·43 [1·04-1·97]; p=0·82 for both) but the precision for the vaccinated subgroup was low. INTERPRETATION: This large national study found a higher hospital admission or emergency care attendance risk for patients with COVID-19 infected with the delta variant compared with the alpha variant. Results suggest that outbreaks of the delta variant in unvaccinated populations might lead to a greater burden on health-care services than the alpha variant. FUNDING: Medical Research Council; UK Research and Innovation; Department of Health and Social Care; and National Institute for Health Research.
Overview
CoChat Summary
TL;DR
In England, sequencing-confirmed SARS-CoV-2 delta cases had higher adjusted risk of hospital admission and emergency care attendance/hospital admission within 14 days than alpha cases. The largest relative increase was for hospital admission (adjusted HR 2·26), although vaccinated-subgroup estimates were imprecise.
Key findings
- Among 43 338 patients (8682 delta, 34 656 alpha; median age 31 years), 196 (2·3%) delta vs 764 (2·2%) alpha patients were admitted to hospital within 14 days; adjusted HR 2·26 (95% CI 1·32–3·89).
- 498 (5·7%) delta vs 1448 (4·2%) alpha patients were admitted to hospital or attended emergency care within 14 days; adjusted HR 1·45 (95% CI 1·08–1·95).
- In unvaccinated patients or those <21 days after first dose, adjusted HRs were 2·32 (1·29–4·16) for hospital admission and 1·43 (1·04–1·97) for hospital admission or emergency care. In vaccinated patients (≥21 days after first dose, with or without second dose), HRs were 1·94 (0·47–8·05) and 1·58 (0·69–3·61), with p=0·82 for interaction and low precision.
- Most patients were unvaccinated: 32 078 (74·0%) across both variant groups.
Methods
- Cohort study in England among all patients with COVID-19 between March 29 and May 23, 2021, identified as infected with alpha or delta by whole-genome sequencing; individual-level data were linked to vaccination, emergency care, hospital admission, and mortality datasets.
- Outcomes were hospital admission only, and emergency care attendance or hospital admission, within 14 days after the first positive specimen. Stratified Cox regression adjusted for age, sex, ethnicity, deprivation, recent international travel, area of residence, calendar week, and vaccination status; secondary analyses estimated HRs by vaccination status.
Limitations
- The paper states administrative-data limitations: SUS reporting delay was mitigated with ECDS data and calendar-week stratification; suboptimal reason-for-visit information could include non-COVID-19-related visits and slightly underestimate HRs; comorbidity data were unavailable and indirectly accounted for via age, sex, ethnicity, and deprivation.
- The paper states 5634 (11·3%) of 49 930 sequenced cases were excluded for missing NHS numbers, with international travellers and minority ethnic groups overrepresented among missing records; systematic differences in excluded individuals cannot be ruled out.
- The paper states sequencing-selection and generalisability concerns: successful sequencing was more likely with low cycle threshold/high viral load, younger age groups and northern England were overrepresented, and differential time from infection to testing could overestimate HRs; vaccinated-subgroup estimates were also limited by low precision.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 Valid · 0 Not valid · 6 Not checked · 27 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the adjusted HR was 1·45 (1·08–1·95).”
- Also stated in: § Findings · plain
“adjusted HR 1·45 [1·08–1·95]”
§ Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study > Introduction
plainstates an associationn = 338- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Also stated in: § Findings · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The HR of hospital admission within 14 days was 2·26 (95% CI 1·32–3·89) after stratification and regression adjustment for confounders.”
- Also stated in: § Findings · plain
“adjusted hazard ratio [HR] 2·26 [95% CI 1·32–3·89]”
§ Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study > Introduction
plainstates an associationn = 338- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Also stated in: § Findings · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Individual-level data on 43 338 COVID-19-positive patients (8682 with the delta variant, 34 656 with the alpha variant; median age 31 years [IQR 17–43]) were included in our analysis.”
- Also stated in: § Results · plain
“Of the 49 930 sequencing-confirmed cases of alpha and delta variants in England from March 29 to May 23, 2021, 43 338 were included in our analysis (appendix p 2).”
§ Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study > Abstract > Findings
plainn = 43,338- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Results · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“498 (5·7%) patients with the delta variant versus 1448 (4·2%) patients with the alpha variant were admitted to hospital or attended emergency care within 14 days”
§ Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study > Abstract > Findings
plainn = 338- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“196 (2·3%) patients with the delta variant versus 764 (2·2%) patients with the alpha variant were admitted to hospital within 14 days after the specimen was taken”
§ Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study > Abstract > Findings
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
11 more claims
Create a free account to see all 33 claims and to verify the 3 references still open.
- Probably not a substantial claim. 16
- It may state two separate claims as one. 5
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Mutations in SARS-CoV-2 that occurred with Delta were found to cause more severe disease in individuals who were not vaccinated than other strains”
From COVID-19, Myocarditis and Pericarditis (2023) · cites this paper as [99]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“In this analysis, we consequently focused on fitting to all-cause excess mortality, which provides a more complete description of the pandemic.15”
From Global impact of the first year of COVID-19 vaccination: a mathematical modelling study (2022) · cites this paper as [15]
Experimental — accuracy not yet measured
Citations
Cites
Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant
Lopez Bernal, J., Andrews, N., Gower, C., Gallagher, E., Simmons, R., Thelwall, S., Stowe, J., Tessier, E., Groves, N., Dabrera, G., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2108891 · Cited by 2,889
Self-citationEstimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England
Davies, N. G., Abbott, S., Barnard, R. C., Jarvis, C. I., Kucharski, A. J., Munday, J. D., Pearson, C. A. B., Russell, T. W., Tully, D. C., Washburne, A. D., et al. (2021) · Science · doi:10.1126/science.abg3055 · Cited by 2,581
Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England
Davies, N. G., Abbott, S., Barnard, R. C., Jarvis, C. I., Kucharski, A. J., Munday, J. D., Pearson, C. A. B., Russell, T. W., Tully, D. C., Washburne, A. D., et al. (2020) · doi:10.1101/2020.12.24.20248822 · Cited by 2,557
Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England
The COVID-19 Genomics UK (COG-UK) consortium, Volz, E., Mishra, S., Chand, M., Barrett, J. C., Johnson, R., Geidelberg, L., Hinsley, W. R., Laydon, D. J., Dabrera, G., et al. (2021) · Nature · doi:10.1038/s41586-021-03470-x · Cited by 1,611
Self-citationSheikh, A., McMenamin, J., Taylor, B., & Robertson, C. (2021) · The Lancet · doi:10.1016/s0140-6736(21)01358-1 · Cited by 939
Self-citationData Resource Profile: Hospital Episode Statistics Admitted Patient Care (HES APC)
Herbert, A., Wijlaars, L., Zylbersztejn, A., Cromwell, D., & Hardelid, P. (2017) · International Journal of Epidemiology · doi:10.1093/ije/dyx015 · Cited by 742
Pijls, B. G., Jolani, S., Atherley, A., Derckx, R. T., Dijkstra, J. I. R., Franssen, G. H. L., Hendriks, S., Richters, A., Venemans-Jellema, A., Zalpuri, S., et al. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-044640 · Cited by 586
SARS-CoV-2 variants of concern are emerging in India
Singh, J., Rahman, S. A., Ehtesham, N. Z., Hira, S., & Hasnain, S. E. (2021) · Nature Medicine · doi:10.1038/s41591-021-01397-4 · Cited by 355
Genomic characterization and Epidemiology of an emerging SARS-CoV-2 variant in Delhi, India
Dhar, M. S., Marwal, R., Radhakrishnan, V., Ponnusamy, K., Jolly, B., Bhoyar, R. C., Sardana, V., Naushin, S., Rophina, M., Mellan, T. A., et al. (2021) · doi:10.1101/2021.06.02.21258076 · Cited by 296
Self-citationAn integrated national scale SARS-CoV-2 genomic surveillance network
(2020) · The Lancet Microbe · doi:10.1016/s2666-5247(20)30054-9 · Cited by 261
Research works printed but not linked: 1
- Stowe, 2021, Effectiveness of COVID-19 vaccines against hospital admission with the delta (B.1.617.2) variant, khub
Cited by
Global impact of the first year of COVID-19 vaccination: a mathematical modelling study
Watson, O. J., Barnsley, G., Toor, J., Hogan, A. B., Winskill, P., & Ghani, A. C. (2022) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(22)00320-6 · Cited by 1,769
“20,21 Any epidemiological differences associated with previous variants were assumed to be reflected by their effects on mortality, 22 which were subsequently captured by the estimated R t trend.”
Nyberg, T., Ferguson, N. M., Nash, S. G., Webster, H. H., Flaxman, S., Andrews, N., Hinsley, W., Bernal, J. L., Kall, M., Bhatt, S., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(22)00462-7 · Cited by 1,221
Self-citationNyberg, T., Ferguson, N. M., Nash, S., Webster, H. H., Flaxman, S. R., Andrews, N. J., Hinsley, W. R., Bernal, J. L., Kall, M. M., Bhatt, S., et al. (2022) · Northumbria Research Link (Northumbria University) · doi:10.17863/cam.81883 · Cited by 1,129
Self-citationFiolet, T., Kherabi, Y., MacDonald, C.-J., Ghosn, J., & Peiffer-Smadja, N. (2022) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2021.10.005 · Cited by 911
SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo
Hui, K. P. Y., Ho, J. C. W., Cheung, M.-C., Ng, K.-C., Ching, R. H. H., Lai, K.-L., Kam, T. T., Gu, H., Sit, K.-Y., Hsin, M. K. Y., et al. (2022) · Nature · doi:10.1038/s41586-022-04479-6 · Cited by 836
Metadata
- Authors
- Twohig, K. A., Nyberg, T., Zaidi, A., Thelwall, S., Sinnathamby, M. A., Aliabadi, S., Seaman, S. R., Harris, R. J., Hope, R., Lopez-Bernal, J., Gallagher, E., Charlett, A., De Angelis, D., Presanis, A. M., Dabrera, G., Koshy, C., Ash, A., Wise, E., Moore, N., Mori, M., Cortes, N., Lynch, J., Kidd, S., Fairley, D., Curran, T., McKenna, J., Adams, H., Fraser, C., Golubchik, T., Bonsall, D., Hassan-Ibrahim, M., Malone, C., Cogger, B., Wantoch, M., Reynolds, N., Warne, B., Maksimovic, J., Spellman, K., McCluggage, K., John, M., Beer, R., Afifi, S., Morgan, S., Marchbank, A., Price, A., Kitchen, C., Gulliver, H., Merrick, I., Southgate, J., Guest, M., Munn, R., Workman, T., Connor, T., Fuller, W., Bresner, C., Snell, L., Patel, A., Charalampous, T., Nebbia, G., Batra, R., Edgeworth, J., Robson, S., Beckett, A., Aanensen, D., Underwood, A., Yeats, C., Abudahab, K., Taylor, B., Menegazzo, M., Clark, G., Smith, W., Khakh, M., Fleming, V., Lister, M., Howson-Wells, H., Berry, L., Boswell, T., Joseph, A., Willingham, I., Jones, C., Holmes, C., Bird, P., Helmer, T., Fallon, K., Tang, J., Raviprakash, V., Campbell, S., Sheriff, N., Blakey, V., Williams, L.-A., Loose, M., Holmes, N., Moore, C., Carlile, M., Wright, V., Sang, F., Debebe, J., Coll, F., Signell, A., Betancor, G., Wilson, H., Eldirdiri, S., Kenyon, A., Davis, T., Pybus, O., du Plessis, L., Zarebski, A., Raghwani, J., Kraemer, M., Francois, S., Attwood, S., Vasylyeva, T., Escalera Zamudio, M., Gutierrez, B., Torok, M. E., Hamilton, W., Goodfellow, I., Hall, G., Jahun, A., Chaudhry, Y., Hosmillo, M., Pinckert, M., Georgana, I., Moses, S., Lowe, H., Bedford, L., Moore, J., Stonehouse, S., Fisher, C., Awan, A., BoYes, J., Breuer, J., Harris, K., Brown, J., Shah, D., Atkinson, L., Lee, J., Storey, N., Flaviani, F., Alcolea-Medina, A., Williams, R., Vernet, G., Chapman, M., Levett, L., Heaney, J., Chatterton, W., Pusok, M., Xu-McCrae, L., Smith, D., Bashton, M., Young, G., Holmes, A., Randell, P., Cox, A., Madona, P., Bolt, F., Price, J., Mookerjee, S., Ragonnet-Cronin, M., F. Nascimento, F., Jorgensen, D., Siveroni, I., Johnson, R., Boyd, O., Geidelberg, L., Volz, E., Rowan, A., Taylor, G., Smollett, K., Loman, N., Quick, J., McMurray, C., Stockton, J., Nicholls, S., Rowe, W., Poplawski, R., McNally, A., Martinez Nunez, R., Mason, J., Robinson, T., O'Toole, E., Watts, J., Breen, C., Cowell, A., Sluga, G., Machin, N., Ahmad, S., George, R., Halstead, F., Sivaprakasam, V., Hogsden, W., Illingworth, C., Jackson, C., Thomson, E., Shepherd, J., Asamaphan, P., Niebel, M., Li, K., Shah, R., Jesudason, N., Tong, L., Broos, A., Mair, D., Nichols, J., Carmichael, S., Nomikou, K., Aranday-Cortes, E., Johnson, N., Starinskij, I., da Silva Filipe, A., Robertson, D., Orton, R., Hughes, J., Vattipally, S., Singer, J., Nickbakhsh, S., Hale, A., Macfarlane-Smith, L., Harper, K., Carden, H., Taha, Y., Payne, B., Burton-Fanning, S., Waugh, S., Collins, J., Eltringham, G., Rushton, S., O'Brien, S., Bradley, A., Maclean, A., Mollett, G., Blacow, R., Templeton, K., McHugh, M., Dewar, R., Wastenge, E., Dervisevic, S., Stanley, R., Meader, E., Coupland, L., Smith, L., Graham, C., Barton, E., Padgett, D., Scott, G., Swindells, E., Greenaway, J., Nelson, A., McCann, C., Yew, W., Andersson, M., Peto, T., Justice, A., Eyre, D., Crook, D., Sloan, T., Duckworth, N., Walsh, S., Chauhan, A., Glaysher, S., Bicknell, K., Wyllie, S., Elliott, S., Lloyd, A., Impey, R., Levene, N., Monaghan, L., Bradley, D., Wyatt, T., Allara, E., Pearson, C., Osman, H., Bosworth, A., Robinson, E., Muir, P., Vipond, I., Hopes, R., Pymont, H., Hutchings, S., Curran, M., Parmar, S., Lackenby, A., Mbisa, T., Platt, S., Miah, S., Bibby, D., Manso, C., Hubb, J., Chand, M., Dabrera, G., Ramsay, M., Bradshaw, D., Thornton, A., Myers, R., Schaefer, U., Groves, N., Gallagher, E., Lee, D., Williams, D., Ellaby, N., Harrison, I., Hartman, H., Manesis, N., Patel, V., Bishop, C., Chalker, V., Ledesma, J., Twohig, K., Holden, M., Shaaban, S., Birchley, A., Adams, A., Davies, A., Gaskin, A., Plimmer, A., Gatica-Wilcox, B., McKerr, C., Moore, C., Williams, C., Heyburn, D., De Lacy, E., Hilvers, E., Downing, F., Shankar, G., Jones, H., Asad, H., Coombes, J., Watkins, J., Evans, J., Fina, L., Gifford, L., Gilbert, L., Graham, L., Perry, M., Morgan, M., Bull, M., Cronin, M., Pacchiarini, N., Craine, N., Jones, R., Howe, R., Corden, S., Rey, S., Kumziene-SummerhaYes, S., Taylor, S., Cottrell, S., Jones, S., Edwards, S., O'Grady, J., Page, A., Mather, A., Baker, D., Rudder, S., Aydin, A., Kay, G., Trotter, A., Alikhan, N.-F., de Oliveira Martins, L., Le-Viet, T., Meadows, L., Casey, A., Ratcliffe, L., Simpson, D., Molnar, Z., Thompson, T., Acheson, E., Masoli, J., Knight, B., Ellard, S., Auckland, C., Jones, C., Mahungu, T., Irish-Tavares, D., Haque, T., Hart, J., Witele, E., Fenton, M., Dadrah, A., Symmonds, A., Saluja, T., Bourgeois, Y., Scarlett, G., Loveson, K., Goudarzi, S., Fearn, C., Cook, K., Dent, H., Paul, H., Partridge, D., Raza, M., Evans, C., Johnson, K., Liggett, S., Baker, P., Bonner, S., Essex, S., Lyons, R., Saeed, K., Mahanama, A., Samaraweera, B., Silveira, S., Pelosi, E., Wilson-Davies, E., Williams, R., Kristiansen, M., Roy, S., Williams, C., Cotic, M., Bayzid, N., Westhorpe, A., Hartley, J., Jannoo, R., Lowe, H., Karamani, A., Ensell, L., Prieto, J., Jeremiah, S., Grammatopoulos, D., Pandey, S., Berry, L., Jones, K., Richter, A., Beggs, A., Best, A., Percival, B., Mirza, J., Megram, O., Mayhew, M., Crawford, L., Ashcroft, F., Moles-Garcia, E., Cumley, N., Smith, C., Bucca, G., Hesketh, A., Blane, B., Girgis, S., Leek, D., Sridhar, S., Forrest, S., Cormie, C., Gill, H., Dias, J., Higginson, E., Maes, M., Young, J., Kermack, L., Gupta, R., Ludden, C., Peacock, S., Palmer, S., Churcher, C., Hadjirin, N., Carabelli, A., Brooks, E., Smith, K., Galai, K., McManus, G., Ruis, C., Davidson, R., Rambaut, A., Williams, T., Balcazar, C., Gallagher, M., O'Toole, Á., Rooke, S., Hill, V., Williamson, K., Stanton, T., Michell, S., Bewshea, C., Temperton, B., Michelsen, M., Warwick-Dugdale, J., Manley, R., Farbos, A., Harrison, J., Sambles, C., Studholme, D., Jeffries, A., Jackson, L., Darby, A., Hiscox, J., Paterson, S., Iturriza-Gomara, M., Jackson, K., Lucaci, A., Vamos, E., Hughes, M., Rainbow, L., Eccles, R., Nelson, C., Whitehead, M., Turtle, L., Haldenby, S., Gregory, R., Gemmell, M., Wierzbicki, C., Webster, H., de Silva, T., Smith, N., Angyal, A., Lindsey, B., Groves, D., Green, L., Wang, D., Freeman, T., Parker, M., Keeley, A., Parsons, P., Tucker, R., Brown, R., Wyles, M., Whiteley, M., Zhang, P., Gallis, M., Louka, S., Constantinidou, C., Unnikrishnan, M., Ott, S., Cheng, J., Bridgewater, H., Frost, L., Taylor-Joyce, G., Stark, R., Baxter, L., Alam, M., Brown, P., Aggarwal, D., Cerda, A., Merrill, T., Wilson, R., McClure, P., Chappell, J., Tsoleridis, T., Ball, J., Buck, D., Todd, J., Green, A., Trebes, A., MacIntyre-Cockett, G., de Cesare, M., Alderton, A., Amato, R., Ariani, C., Beale, M., Beaver, C., Bellis, K., Betteridge, E., Bonfield, J., Danesh, J., Dorman, M., Drury, E., Farr, B., Foulser, L., Goncalves, S., Goodwin, S., Gourtovaia, M., Harrison, E., Jackson, D., Jamrozy, D., Johnston, I., Kane, L., Kay, S., Keatley, J.-P., Kwiatkowski, D., Langford, C., Lawniczak, M., Letchford, L., Livett, R., Lo, S., Martincorena, I., McGuigan, S., Nelson, R., Palmer, S., Park, N., Patel, M., Prestwood, L., Puethe, C., Quail, M., Rajatileka, S., Scott, C., Shirley, L., Sillitoe, J., Spencer Chapman, M., Thurston, S., Tonkin-Hill, G., Weldon, D., Rajan, D., Bronner, I., Aigrain, L., Redshaw, N., Lensing, S., Davies, R., Whitwham, A., Liddle, J., Lewis, K., Tovar-Corona, J., Leonard, S., Durham, J., Bassett, A., McCarthy, S., Moll, R., James, K., Oliver, K., Makunin, A., Barrett, J., & Gunson, R.
- Affiliations
- Public Health England (GB)
- University of Cambridge (GB)
- Corresponding author
- Twohig, Katherine A
- ORCID
- Twohig, Katherine A
- Nyberg, Tommy
- Zaidi, Asad
- Thelwall, Simon
- Sinnathamby, Mary A
- Aliabadi, Shirin
- Seaman, Shaun R
- Harris, Ross J
- Hope, Russell
- Lopez-Bernal, Jamie
- Charlett, Andre
- De Angelis, Daniela
- Presanis, Anne M
- Wise, Emma
- Golubchik, Tanya
- Snell, Luke
- Nebbia, Gaia
- Beckett, Angela
- Yeats, Corin
- Tang, Julian
- Coll, Francesc
- Signell, Adrian
- Betancor, Gilberto
- Wilson, Harry
- Kraemer, Moritz
- Jahun, Aminu
- Pinckert, Malte
- Georgana, Iliana
- Moses, Samuel
- Breuer, Judith
- Harris, Kathryn
- Brown, Julianne
- Shah, Divya
- Storey, Nathaniel
- Flaviani, Flavia
- Alcolea-Medina, Adela
- Bashton, Matthew
- Holmes, Alison
- Randell, Paul
- Price, James
- Jorgensen, David
- Smollett, Katherine
- Ahmad, Shazaad
- Mair, Daniel
- Nomikou, Kyriaki
- Robertson, David
- Harper, Katherine
- Dervisevic, Samir
- McCann, Clare
- Eyre, David
- Sloan, Tim
- Glaysher, Sharon
- Allara, Elias
- Lackenby, Angie
- Miah, Shahjahan
- Bibby, David
- Chand, Meera
- Bradshaw, Daniel
- Myers, Richard
- Ledesma, Juan
- Moore, Catherine
- Rudder, Steven
- Aydin, Alp
- Alikhan, Nabil-Fareed
- Masoli, Jane
- Haque, Tanzina
- Bourgeois, Yann
- Partridge, David
- Williams, Rachel
- Roy, Sunando
- Williams, Charlotte
- Cotic, Marius
- Bayzid, Nadua
- Westhorpe, Adam
- Hartley, John
- Lowe, Helen
- Ensell, Leah
- Beggs, Andrew
- Megram, Oliver
- Bucca, Giselda
- Girgis, Sophia
- Rambaut, Andrew
- Williamson, Kathleen
- Stanton, Thomas
- Bewshea, Claire
- Farbos, Audrey
- Jackson, Leigh
- Hiscox, Julian
- Paterson, Steve
- Turtle, Lance
- Haldenby, Sam
- Gemmell, Matthew
- Wierzbicki, Claudia
- Webster, Hermione
- Louka, Stavroula
- Unnikrishnan, Meera
- Bridgewater, Hannah
- Aggarwal, Dinesh
- Todd, John
- Beale, Mathew
- Danesh, John
- Dorman, Matthew
- Kane, Leanne
- Lawniczak, Mara
- Lo, Stephanie
- Aigrain, Louise
- Venue
- The Lancet Infectious Diseases
- Publisher
- Elsevier BV
- Published
- 2022-01
- Volume
- 22
- Issue
- 1
- Pages
- 35-42
- ISSN
- 1473-3099 (ISSN-L)
- PMC
- PMC8397301
- OpenAlex
- W3198487015
- Cited by
- 803
- References
- 21
- Citations by year
- 2026: 28 · 2025: 41 · 2024: 87 · 2023: 194 · 2022: 323
- FWCI
- 57.49
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by/4.0/ (vor)
- Locations
- The Lancet Infectious Diseases (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (publishedVersion, cc-by)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion, cc-by-sa)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- Warwick Research Archive Portal (University of Warwick) (acceptedVersion)
- ePrints Soton (University of Southampton) (submittedVersion)
- UEA Digital Repository (University of East Anglia) (submittedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Physical Sciences › Mathematics › Modeling and Simulation › COVID-19 epidemiological studies
- Keywords
- Delta variant, Alpha variant, COVID-19 severity, hospitalization, COVID-19 vaccination status, unvaccinated patients, disease severity risk factors, whole genome sequencing, England, vaccine hesitancy
- MeSH terms
- COVID-19, SARS-CoV-2, Adolescent, Adult, Aged, Aged, 80 and over, Child, Child, Preschool, Emergency Medical Services, England, Female, Hospitalization, Humans, Male, Middle Aged, Severity of Illness Index, Cohort Studies, Proportional Hazards Models, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-05, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-05 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study. https://app.cochat.ai/papers/10.1016/s1473-3099(21)00475-8
- The paper
- Twohig, K. A., Nyberg, T., Zaidi, A., Thelwall, S., Sinnathamby, M. A., Aliabadi, S., Seaman, S. R., Harris, R. J., Hope, R., Lopez-Bernal, J., Gallagher, E., Charlett, A., De Angelis, D., Presanis, A. M., Dabrera, G., Koshy, C., Ash, A., Wise, E., Moore, N., . . . Gunson, R. (2022). Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study. The Lancet Infectious Diseases. https://doi.org/10.1016/s1473-3099(21)00475-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.